Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting.

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting. Abstract Text:

Susan M Schwartz,Vidhu P Bansal,Cecilia Hale,Maureen Rossi,Janet P Engle,

Objective:The study was conducted to provide information on how consumers would use orlistat 60 mg, especially in terms of product dosing, in a setting without physician supervision.Methods and Procedures:A 3-month, open-label, naturalistic study was conducted in an over-the-counter (OTC) setting in 18 pharmacies. Consumers >/=18 years were allowed to purchase orlistat packages containing a bottle of orlistat 60 mg plus educational materials, which provided lifestyle information and tools to encourage successful weight loss. Data were collected at pharmacy visits and during telephone interviews at 14, 30, 60, and 90 days after enrollment.Results:A total of 237 subjects purchased and used the product, and completed at least one interview. Most subjects followed the dosing directions and took two to three capsules per day with meals throughout the study. The majority of subjects took a daily multivitamin, as directed. Approximately, 80% of subjects used the educational materials and found them useful or very useful. Over the study duration, most subjects reported following a diet and 51% of subjects reported more frequent or longer exercise than at enrollment. Approximately, 80% of subjects indicated they were satisfied or very satisfied with the weight loss achieved; measured and self-reported relative median weight loss was approximately 5% after >/=60 days of using orlistat. Most common adverse events were gastrointestinal (GI), and majority of subjects did not interrupt or discontinue orlistat due to these GI events.Discussion:These results demonstrate that orlistat 60 mg can be used appropriately and safely and with high consumer satisfaction without physician supervision or dietary counseling. Collectively, results indicate that orlistat 60 mg is an appropriate weight loss therapy in the OTC environment.Obesity (2008) 16 3, 623-629. doi:10.1038/oby.2007.96.

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting. Publishing Authors By Initials

SM Schwartz,VP Bansal,C Hale,M Rossi,JP Engle,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Obesity (Silver Spring, Md.)

VOLUME: 16

Page Numbers: 623-9

Journal Abbreviation: Obesity (Silver Spring)

ISSN: 1930-7381

DAY: 24

MONTH: 01

YEAR: 2008

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101264860

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting.

AFFILIATION: [1] 1Roche Consumer Health, Nutley, New Jersey, USA [2] 4Present address: R & D, GlaxoSmithKline Consumer Healthcare, Parsippany, New Jersey, USA (S.M.S.), Drug Safety, Hoffmann-La Roche, Nutley, New Jersey, USA (M.R.).

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Obesity (Silver Spring)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting Related Publications

• Body-image thought processes: The development and initial validation of the Assessment of Body-Image Cognitive Distortions.
• Care of the living, care of the dying: reconceptualizing nursing home care.
• Clinical aspects of developmental neurology.
• Comparison of nonelective removal of percutaneously versus surgically placed central venous catheters in high-risk neonates.
• Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting.
• Congenital pulmonary arteriovenous fistula producing pulmonary arterial steal syndrome.
• Cryptorchism; pathogenesis and treatment.
• Deoxyribonucleic acid (DNA) content of human ovarian tumors in relation to histological grading.
• Depressive personality disorder, dysthymia, and their relationship to perfectionism.
• EOSINOPHILIC LEUKAEMIA WITH PH1-POSITIVE CELLS.
• Effect of neutron radiation on the human testes; a case report.
• Effects of incentive on working memory capacity: Behavioral and pupillometric data.
• Histochemical studies on abnormal growth of human endometrium; cytoplasmic ribonucleic acids in normal and pathological glandular epithelium.
• Improving patient outcomes of home health care: findings from two demonstration trials of outcome-based quality improvement.
• Magnetic resonance imaging of innervational and extraocular muscle abnormalities in Duane-radial ray syndrome.
• Nursing home staff as research partners.
• On the division of short-term and working memory: an examination of simple and complex span and their relation to higher order abilities.
• On the validity of the hyperemia method for determining ovulation time in women.
• Recovery from complete heart block in diphtheria.
• Relation of structure of purine and pyrimidine nucleosides to antitumor activity.
• Speed and accuracy of accessing information in working memory: An individual differences investigation of focus switching.
• Studies on the nature of the protein catabolic response to adrenal cortical extract; accentuation by insulin hypoglycemia.
• Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
• The evolution, uses, and present problems of the patient's medical record as exemplified by the records of the New York Hospital from 1793 to the present.
• The measurement of body-image dissatisfaction-satisfaction: is rating importance important?
• The role of phospholipase Cgamma1 tyrosine phosphorylation during phasic myometrial contractions.
• Three novel mutations in KIF21A highlight the importance of the third coiled-coil stalk domain in the etiology of CFEOM1.
• Tissue prothrombinase activity in myometrium from timed-pregnant rats.
• Transient complete heart block following percutaneous balloon pulmonary valvuloplasty: treatment with systemic corticosteroids.
• What's new in medicine and surgery.